BMO Capital raised today Denison Mines (DNN.US) to 'market outperform', leaving shares price target unchanged at 3 CAD vs 2.5 CAD on market (1.9 USD). Recent days are bringing renewed interest in the uranium sector, following the reactivation of the Three Miles Island nuclear power plant, Constellation Energy (CEG.US), the energy from which will be used for the development of AI in Microsoft's (MSFT.US) data centers.
- As a result, the market sees opportunities, with more nuclear power plants opening and higher final demand for uranium ore (U308), which could re-energize the mining sector, as well as spot prices for ore. Recent days have also brought greater analyst interest in stocks, related to uranium
- In BMO's view, Denison offers one of the most attractive price-to-net asset value ratios, at their 0.9 times, with potential catalysts, in the short term. BMO believes that Denison, with a stockpile of 2.2 million pounds of uranium.
- Analysts have assessed that BMO now has one of the strongest balance sheets to finance the Phoenix uranium mining project, with in-situ mining (ISR) technology that can reduce the cost of exploring the deposit and significantly extend its life.
Denison Mines (DNN.US, D1 interval)
The stock broke out above the 200- and 100-session moving averages (EMA) on the daily interval today, signaling an exit from the downtrend.
Source: xStation5
US OPEN: Powell, MAG7 and Trump mix market's sentiment
Amazon preview: all eyes on AWS and AI strategy 🔎
Apple Preview: Will Asia spoil the earnings?
DAX: DE40 loses ahead of the EBC decision 📉Volkswagen under pressure
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
